Hepatitis b. hepatitis e antigen determines treatment course. Hep b e antigen positive which turns negative can stop treatment.
Reply to this Note | Notes Linking Here | Edit
Showing first five replies; total replies are 1. See all Replies
Hepatitis b. eight different genotypes. Rarely affects treatment. Hbv replication serologies are hbeag antihbe hbv DNA. ...Read more
Hepatitis b. hepatitis e antigen determines treatment course. Hep b e antigen positive which turns negative can stop treatment.
...Read more
Hepatitis b. eight different genotypes. Rarely affects treatment. Hbv replication serologies are hbeag antihbe hbv DNA.
...Read more
Autoimmune hepatitis presents with ast and alt elevations greater than fifteen times upper limit of normal. Check spep, then check ana and anti smooth muscle antibody.
...Read more
Xifaxan 550 mg PO BID for hepatic encephalopathy. Rifaximin.
...Read more
Hepatitis B "treated with telbivudine were therefore significantly more likely to show HBeAg seroconversion than those receiving entecavir"
...Read more
Hepatitis B "interval between HCC surveillance tests is 6–12 months"
...Read more
Hepatitis C Labs for therapy - genotype, rna viral load, cbc, cmp, pt/inr, fibrosure. Ultrasound.
...Read more
Epclusa for 12 weeks genotype 2 hepatitis C 99 percent cure rate. December 2017. Add ribavirin for Child Pugh B and C for 12 weeks.
...Read more
Check viral load 12 weeks after Epclusa therapy for hepatitis C. Can check viral load at 4 weeks.
...Read more
Alcoholic cirrhosis - ascites, hepatic encephalopathy. Ordered cirrhosis panel, ascites panel, and AFP. Lactulose titrated to 3 bowel movements per day. Discharge on spironolactone 100 mg PO qday and Lasix 40 mg PO qday. Can follow up with me in clinic to discuss EGD with possible variceal banding. Gastroenterology will sign off. Please call with questions.
...Read more